Applied DNA Sciences announced significant amendments to its corporate bylaws on November 7, 2024, following approval by its board of directors. The key changes include reducing the required quorum for stockholder meetings from a majority to one-third of issued and outstanding voting shares.The amendments also grant new authority to the company's CEO to adjourn any stockholder meetings. These changes, implemented through a Certificate of Amendment, became effective immediately upon execution by a duly authorized officer.

Applied DNA Sciences announced significant amendments to its corporate bylaws on November 7, 2024, following approval by its board of directors. The key changes include reducing the required quorum for stockholder meetings from a majority to one-third of issued and outstanding voting shares.The amendments also grant new authority to the company's CEO to adjourn any stockholder meetings. These changes, implemented through a Certificate of Amendment, became effective immediately upon execution by a duly authorized officer.